S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
NYSE:CANO

Cano Health Stock Forecast, Price & News

$14.06
-0.42 (-2.90 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.97
$14.50
50-Day Range
$9.66
$15.44
52-Week Range
$9.20
$17.43
Volume2.60 million shs
Average Volume1.85 million shs
Market Capitalization$6.75 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.5
30 days | 90 days | 365 days | Advanced Chart
Receive CANO News and Ratings via Email

Sign-up to receive the latest news and ratings for Cano Health and its competitors with MarketBeat's FREE daily newsletter.


About Cano Health

Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management. Cano Health, LLC was founded in 2009 and is based in Miami, Florida.

Headlines

Cano Health, Inc. (NYSE:CANO) Short Interest Update
Cano Health, Inc. (NYSE:CANO) Short Interest Update
September 21, 2021 |  americanbankingnews.com
Citigroup Initiates Coverage on Cano Health (NYSE:CANO)
Citigroup Initiates Coverage on Cano Health (NYSE:CANO)
September 21, 2021 |  americanbankingnews.com
Cano Health (NYSE:CANO) Shares Up 6.7%
Cano Health (NYSE:CANO) Shares Up 6.7%
September 10, 2021 |  americanbankingnews.com
Cowen Initiates Coverage on Cano Health (NYSE:CANO)
Cowen Initiates Coverage on Cano Health (NYSE:CANO)
September 9, 2021 |  americanbankingnews.com
Cano Health Enters Rio Grande Valley, Texas
Cano Health Enters Rio Grande Valley, Texas
September 9, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.03 out of 5 stars

Medical Sector

531st out of 1,351 stocks

Offices & Clinics Of Medical Doctors Industry

5th out of 11 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Cano Health (NYSE:CANO) Frequently Asked Questions

Is Cano Health a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cano Health stock.
View analyst ratings for Cano Health
or view top-rated stocks.

What stocks does MarketBeat like better than Cano Health?

Wall Street analysts have given Cano Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cano Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cano Health?

Cano Health saw a increase in short interest in August. As of August 31st, there was short interest totaling 15,440,000 shares, an increase of 23.2% from the August 15th total of 12,530,000 shares. Based on an average daily trading volume, of 2,790,000 shares, the short-interest ratio is currently 5.5 days. Approximately 9.3% of the company's stock are short sold.
View Cano Health's Short Interest
.

When is Cano Health's next earnings date?

Cano Health is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Cano Health
.

What guidance has Cano Health issued on next quarter's earnings?

Cano Health issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.60 billion-$1.60 billion, compared to the consensus revenue estimate of $1.50 billion.

What price target have analysts set for CANO?

3 Wall Street analysts have issued 1-year price objectives for Cano Health's shares. Their forecasts range from $18.00 to $20.00. On average, they anticipate Cano Health's stock price to reach $18.67 in the next twelve months. This suggests a possible upside of 32.8% from the stock's current price.
View analysts' price targets for Cano Health
or view top-rated stocks among Wall Street analysts.

Who are Cano Health's key executives?

Cano Health's management team includes the following people:
  • Dr. Marlow Hernandez Cano, Founder, CEO & Director
  • Mr. Brian D. Koppy, Chief Financial Officer (Age 52)
  • Dr. John J. McGoohan IV, COO & Chief Strategy Officer
  • Mr. Carlos Zuniga, Sr. VP of Operations & CTO
  • Mr. David J. Armstrong, Chief Compliance Officer & Gen. Counsel
  • Ms. Jennifer Fernandez, Chief People Officer
  • Dr. Richard Aguilar M.D., Chief Clinical Officer
  • Ms. Barbara Ferreiro, Chief Brand Officer
  • Ms. Greidys Maleta, Pres of Coding, Credentialing & Care Coordination
  • Mr. Enrique Zamora, Pres of Belen Medical Centers

What is Cano Health's stock symbol?

Cano Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CANO."

Who are Cano Health's major shareholders?

Cano Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include FMR LLC (42.01%), Third Point LLC (12.85%), ArrowMark Colorado Holdings LLC (12.80%), Maverick Capital Ltd. (9.69%), Owl Creek Asset Management L.P. (5.69%) and LMR Partners LLP (3.09%). Company insiders that own Cano Health stock include Marlow Hernandez and Richard Aguilar.
View institutional ownership trends for Cano Health
.

Which institutional investors are buying Cano Health stock?

CANO stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Third Point LLC, ArrowMark Colorado Holdings LLC, Maverick Capital Ltd., Owl Creek Asset Management L.P., LMR Partners LLP, Mason Capital Management LLC, and PFM Health Sciences LP. Company insiders that have bought Cano Health stock in the last two years include Marlow Hernandez, and Richard Aguilar.
View insider buying and selling activity for Cano Health
or or view top insider-buying stocks.

How do I buy shares of Cano Health?

Shares of CANO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cano Health's stock price today?

One share of CANO stock can currently be purchased for approximately $14.06.

How much money does Cano Health make?

Cano Health has a market capitalization of $6.75 billion.

What is Cano Health's official website?

The official website for Cano Health is canohealth.com.

Where are Cano Health's headquarters?

How can I contact Cano Health?

Cano Health's mailing address is 1601 WASHINGTON AVENUE SUITE 800, MIAMI BEACH FL, 33139. The company can be reached via phone at 855-226-6633 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.